The demonstration that Paneth cell accumulation specifically in the adenoma samples correlating with higher levels of nuclear β-catenin and ICN1, and differential EPHB2 distribution led us to study the possibility that Paneth cells may serve as a prognosis marker in low-grade tumor patients. The gene discussed is EPHB2; the disease is neoplasm.